Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...

The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...

Sarepta will discontinue its next generation of exon-skipping drugs for Duchenne muscular dystrophy over safety concerns, in ...

Elevidys sales have increased since the FDA made a controversial choice to expand the therapy's use. Meanwhile, Sarepta is ...

Reorganizing its generics business strategy to target 60% instead of 80% of drugs coming off patent and reallocating resources to complex generics will help Teva offset base business erosion and ...

International Flavors & Fragrances is a global leader in the flavors, fragrances, and biosciences specialty ingredients space. The company's portfolio has changed in recent years with the acquisition ...

The early success of our newest product, AGAMREE, along with the continued robust ... Try Now>> See the top stocks recommended by analysts >> Read More on CPRX: Catalyst Pharmaceutical Partners ...

Revenue of $5.0 billion, increased 3.0% year-over-year or 2.7% in constant currency1, the high end of our guidance ranges Operating margin of 14.6%, sequentially flat and increased 60 ...